
Gingival Recession Market Report 2026
Global Outlook – By Treatment Method (Soft Tissue Grafting, Regenerative Procedures, Pinhole Surgical Technique (PST)), By Product Type (Tissue Regenerative Materials, Bone Grafting Materials), By End-User (Hospitals, Dental Clinics, Research Institutes) - Market Size, Trends, And Global Forecast 2026-2035
Gingival Recession Market Overview
• Gingival Recession market size has reached to $3.29 billion in 2025 • Expected to grow to $4.42 billion in 2030 at a compound annual growth rate (CAGR) of 6% • Growth Driver: Increasing Awareness Of Oral Health Fueling The Growth Of The Market Due To Rising Focus On Prevention And Treatment Of Dental Issues • Market Trend: Advancing Gingival Recession Treatment With Injectable Regenerative Therapy • North America was the largest region in 2025.What Is Covered Under Gingival Recession Market?
Gingival recession is a dental condition in which the gum tissue surrounding the teeth pulls back or wears away, exposing more of the tooth or its root. This can lead to increased sensitivity, a higher risk of cavities, and aesthetic concerns. Gingival recession may result from factors such as aggressive brushing, periodontal disease, genetics, or misaligned teeth. The main treatment methods for gingival recession are soft tissue grafting, regenerative procedures, and pinhole surgical technique (PST). The soft tissue grafting procedure involves taking healthy gum tissue, often from the roof of the mouth, and attaching it to areas where gums have receded. The goal is to cover exposed tooth roots, reduce sensitivity, and improve the appearance of the gums. Product types include tissue regenerative materials and bone grafting materials, which are used by various end-users such as hospitals, dental clinics, research institutes, and others.
What Is The Gingival Recession Market Size and Share 2026?
The gingival recession market size has grown strongly in recent years. It will grow from $3.29 billion in 2025 to $3.5 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to periodontal disease prevalence, growth of dental clinics, early adoption of grafting techniques, cosmetic dentistry demand, oral hygiene awareness.What Is The Gingival Recession Market Growth Forecast?
The gingival recession market size is expected to see strong growth in the next few years. It will grow to $4.42 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to advances in regenerative dentistry, growth of laser-based procedures, increasing dental tourism, patient preference for minimally invasive care, rising dental expenditure. Major trends in the forecast period include rising demand for minimally invasive procedures, increased use of regenerative dental materials, growing adoption of pinhole surgical technique, improved aesthetic dental outcomes, expansion of preventive dental care.Global Gingival Recession Market Segmentation
1) By Treatment Method: Soft Tissue Grafting, Regenerative Procedures, Pinhole Surgical Technique (PST) 2) By Product Type: Tissue Regenerative Materials, Bone Grafting Materials 3) By End-User: Hospitals, Dental Clinics, Research Institutes Subsegments: 1) By Soft Tissue Grafting: Free Gingival Graft, Connective Tissue Graft, Pedicle Graft, Allograft 2) By Regenerative Procedures: Guided Tissue Regeneration (GTR), Enamel Matrix Derivatives (EMD), Platelet-Rich Fibrin (PRF), Bone Grafting 3) By Pinhole Surgical Technique (PST): Minimally Invasive Recession Coverage, Collagen Membrane Application, Scalpel-Free Gum RejuvenationWhat Is The Driver Of The Gingival Recession Market?
The increasing awareness of oral health is expected to propel the growth of the gingival recession market going forward. Oral health refers to the condition of the teeth, gums, and mouth, ensuring they are free from disease, pain, or infection for proper function and overall well-being. Awareness of oral health is rising due to increasing access to information through digital media and healthcare campaigns, highlighting its impact on overall well-being. Gingival recession is a noticeable and often painful sign of poor oral health, driving individuals to learn about its causes, prevention, and treatment, thereby enhancing awareness of proper oral hygiene practices. For instance, in January 2024, according to a report published by the Manchester Health and Wellbeing Board, a UK-based partnership organization, between July 2022 and June 2023, 78,230 children under 18 received treatment from an NHS dentist in Manchester, reflecting an increase of 13,488 children (20.8%) compared to the previous year. Therefore, the increasing awareness of oral health is driving the growth of the gingival recession industry.Key Players In The Global Gingival Recession Market
Major companies operating in the gingival recession market are Alfa‑Perio Ltd, Zimmer Biomet Dental, Institut Straumann AG, LifeNet Health, BioHorizons, Geistlich Pharma AG, osteocom, Dentevim Dental Clinic, Uniqa Dental LTD, Focus Dental, Premiere Dental Care Center, Dentsply Sirona, ZimVie Inc, Tissue Regenix, Septodont Holding, Medical Consult Implants GmbH, Regedent AG, Regenity Biosciences, Nobel Biocare Services AG, Bioteck S.p.A, Maxigen Biotech IncGlobal Gingival Recession Market Trends and Insights
Major companies operating in the gingival recession market are developing innovative treatments, such as injectable regenerative tissue advancement therapy, to enhance soft and hard tissue regeneration, improve treatment outcomes, and address unmet needs in oral healthcare. An injectable regenerative tissue therapy is a minimally invasive treatment that stimulates natural healing and restores both soft and hard tissues by promoting tissue regeneration. For instance, in February 2025, BioCellgraft, Inc., a US-based biotechnology and regenerative medicine company, introduced OraFyl. OraFyl's injectable formulation sets it apart from traditional grafting techniques in oral tissue regeneration. Unlike conventional surgical procedures that require extensive intervention and prolonged recovery, OraFyl provides a minimally invasive solution for addressing gum recession, papilla loss, and alveolar socket management. Utilizing a human connective tissue matrix (HCTM), it supports the body’s natural healing process, potentially speeding up recovery, reducing patient discomfort, lowering treatment costs, and improving clinical outcomes.What Are Latest Mergers And Acquisitions In The Gingival Recession Market?
In January 2025, Branford Castle Partners, a US-based private equity firm, acquired Eastern Dental Management for an undisclosed amount. The acquisition aligns with Branford Castle's investment approach of targeting companies with strong competitive advantages and leadership positions in niche industries. Eastern Dental Management is a US-based dental services company that offers treatments for various dental conditions, including gingival recession.Regional Outlook
North America was the largest region in the gingival recession market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Gingival Recession Market?
The gingival recession market consists of revenues earned by entities providing services such as preventive services, cosmetic procedures, and restorative solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The gingival recession market also includes sales of gingival contouring lasers, pinhole surgical instruments, and desensitizing agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Gingival Recession Market Report 2026?
The gingival recession market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gingival recession industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Gingival Recession Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $3.5 billion |
| Revenue Forecast In 2035 | $4.42 billion |
| Growth Rate | CAGR of 6.3% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Treatment Method, Product Type, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Alfa‑Perio Ltd, Zimmer Biomet Dental, Institut Straumann AG, LifeNet Health, BioHorizons, Geistlich Pharma AG, osteocom, Dentevim Dental Clinic, Uniqa Dental LTD, Focus Dental, Premiere Dental Care Center, Dentsply Sirona, ZimVie Inc, Tissue Regenix, Septodont Holding, Medical Consult Implants GmbH, Regedent AG, Regenity Biosciences, Nobel Biocare Services AG, Bioteck S.p.A, Maxigen Biotech Inc |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
